Richard Caimi
pharmaceutical & healthcare
"r FSSI/COCOBIND, INC"
Belgium
Biography
GlaxoSmithKline (GSK) is one of the world’s leading research-based pharmaceutical & healthcare companies, employing over 100,000 people globally with offices in more than 115 countries. GSK has major research centers in the UK, USA, & Spain, Belgium & China & an extensive manufacturing network with 84 sites globally. Listed on the London Stock Exchange, Group turnover for 2016 was approx £27.9B.
Research Interest
Our innovative pipeline covers 6 core areas; Vaccines, Respiratory Diseases, Infectious Disease / HIV, Immuno-inflammation, Rare Diseases, Oncology. We currently have ~40 new molecules, vaccines & biologicals in Phase II/III development of which approximately 80% have the potential to be 1st in class. The depth & breadth of our pipeline marks a new chapter in R&D productivity; we have the potential to file up 20 assets prior to 2020 & a further 20 additional products between 2020 & 2025.
